Maria E Joosse

4PUBLICATIONS
26CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Infant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 31, 2026
Neutralizing the IL-12/IL-23 p40 subunit prevents immune checkpoint blockade toxicity without compromising antitumor efficacy.

|Jun 22, 2022
Low-Dose JAK3 Inhibition Improves Antitumor T-Cell Immunity and Immunotherapy Efficacy.

Floris Dammeijer, Mandy van Gulijk, Larissa Klaase

|Feb 16, 2021
Exome sequencing in patient-parent trios suggests new candidate genes for early-onset primary sclerosing cholangitis.

Sjoukje-Marije Haisma, Rinse K Weersma, Maria E Joosse

|Jun 02, 2019
Disease progression in paediatric- and adult-onset sclerosing cholangitis: Results from two independent Dutch registries.

Maria E Joosse, Sjoukje M Haisma, Marlou F M Sterk

Pageof 1

Frequent Collaborators

2 joint publications

Floris Dammeijer

2 joint publications

Menno van Nimwegen

2 joint publications

Joachim G J V Aerts

1 joint publications

Sjoukje-Marije Haisma